Showing results (5181-5190 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|August 28, 2025
New Vaccine Introduction in Middle-Income Countries Across the Middle East and North Africa-Progress and ChallengesChrissy Bishop, Deeksha Parashar, Diana Kizza, et al.Vaccines|August 28, 2025
Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of Toxoplasma gondiiHae-Ji Kang, Fu-Shi QuanVaccines|August 28, 2025
Research Progress of Universal Influenza VaccineLiangliang Wang, Qian Xie, Pengju Yu, et al.Vaccines|August 28, 2025
Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target IdentificationLena Pfitzer, Gitta Boons, Lien Lybaert, et al.Vaccines|August 28, 2025
Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 VaccinationHeiko Pfister, Carsten Uhlig, Zsuzsanna Mayer, et al.Vaccines|August 28, 2025
Protective Efficacy of Subunit Vaccine Expressing Rv0976c Against TuberculosisZiwei Zhou, Dan Chen, Fuzeng Chen, et al.Vaccines|August 28, 2025
Therapeutic Vaccines for Non-Communicable Diseases: Global Progress and China's Deployment PathwaysYifan Huang, Xiaohang Lyu, Yiu-Wing KamVaccines|August 28, 2025
Decrypting the Immune Symphony for RNA VaccinesBrian Weidensee, Itishri SahuVaccines|August 28, 2025
Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A/H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet InjectionVladimir A Yakovlev, Victoria R Litvinova, Nadezhda B Rudometova, et al.Vaccines|August 28, 2025
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974Kristen Feemster, William P Hausdorff, Natalie Banniettis, et al.Pageof 1,039